Rigshospitalet wants to break the code on patients with immune deficiency

A new Research Platform at Rigshospitalet is about to investigate how the treatment of immune defective patients with diagnoses such as Cancer and HIV can be optimized. Rigshospitalet has recently been granted 60 million DKK by the Danish Research Foundation to the project, which is the first of its kind in Denmark.
Responsible editor